117 related articles for article (PubMed ID: 27312546)
1. Effect of Carbamazepine 10, 11-Epoxide on Serum Carbamazepine Measurement Using a New CMIA Assay: Comparison of Values Obtained by Using PETINIA, CEDIA and Liquid Chromatography Combined with Tandem Mass Spectrometry.
Dasgupta A; Davis B; Slawson MH; Johnson-Davis KL
Ann Clin Lab Sci; 2016 May; 46(3):242-6. PubMed ID: 27312546
[TBL] [Abstract][Full Text] [Related]
2. Analytical Performance Evaluation of a New Cobas Tacrolimus Assay on Cobas e411 Analyzer: Comparison of Values Obtained by the CMIA Tacrolimus Assay and a Liquid Chromatography Combined with Tandem Mass Spectrometric Method.
Dasgupta A; Khalil SA; Johnson-Davis KL
Ann Clin Lab Sci; 2016; 46(2):204-8. PubMed ID: 27098629
[TBL] [Abstract][Full Text] [Related]
3. Discordant carbamazepine values between two immunoassays: carbamazepine values determined by ADVIA Centaur correlate better with those determined by LC-MS/MS than PETINIA assay.
McMillin GA; Juenke JM; Johnson MJ; Dasgupta A
J Clin Lab Anal; 2011; 25(3):212-6. PubMed ID: 21567471
[TBL] [Abstract][Full Text] [Related]
4. Estimation of carbamazepine and carbamazepine-10,11-epoxide concentrations in plasma using mathematical equations generated with two carbamazepine immunoassays.
McMillin GA; Juenke JM; Tso G; Dasgupta A
Am J Clin Pathol; 2010 May; 133(5):728-36. PubMed ID: 20395519
[TBL] [Abstract][Full Text] [Related]
5. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
[TBL] [Abstract][Full Text] [Related]
6. Analytic performance evaluation of a new turbidimetric immunoassay for carbamazepine on the ADVIA 1650 analyzer: effect of carbamazepine 10,11-epoxide.
Dasgupta A; Datta P
Ther Drug Monit; 2005 Feb; 27(1):31-4. PubMed ID: 15665743
[TBL] [Abstract][Full Text] [Related]
7. PETINIA total phenytoin assay on the vista 1500 analyzer is not suitable for monitoring free phenytoin concentration if ultrafiltration is performed at room temperature.
Dasgupta A; Everett JM; Davis B
Ther Drug Monit; 2013 Jun; 35(3):384-7. PubMed ID: 23666578
[TBL] [Abstract][Full Text] [Related]
8. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method.
Dasgupta A; Tso G; Chow L
Clin Biochem; 2013 May; 46(7-8):685-7. PubMed ID: 23219740
[TBL] [Abstract][Full Text] [Related]
11. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of carbamazepine-10,11-epoxide in human serum and plasma.
Schierscher T; Singh N; Kobel A; Wild J; Bauland F; Geistanger A; Risch L; Geletneky C; Seger C; Taibon J
Clin Chem Lab Med; 2024 Jun; 62(7):1339-1351. PubMed ID: 38515344
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA).
Parant F; Moulsma M; Gagnieu MC; Lardet G
Ther Drug Monit; 2005 Aug; 27(4):457-62. PubMed ID: 16044102
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000.
Parant F; Bossu H; Gagnieu MC; Lardet G; Moulsma M
Ther Drug Monit; 2003 Feb; 25(1):41-5. PubMed ID: 12548143
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Response of DRI Oxycodone Semiquantitative Immunoassay With True Oxycodone Values Determined by Liquid Chromatography Combined With Tandem Mass Spectrometry: Sensitivity of the DRI Assay at 100 ng/ml Cut-Off and Validity of Semiquantitative Value.
Dixon RB; Davis B; Dasgupta A
J Clin Lab Anal; 2016 May; 30(3):190-5. PubMed ID: 25715994
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients.
Ham JY; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD; Won DI; Song KE; Cho JH
Scand J Clin Lab Invest; 2016 Jul; 76(4):296-303. PubMed ID: 26981890
[TBL] [Abstract][Full Text] [Related]
16. Routine therapeutic monitoring of the active metabolite of carbamazepine: Is it really necessary?
Burianová I; Bořecká K
Clin Biochem; 2015 Sep; 48(13-14):866-9. PubMed ID: 26018946
[TBL] [Abstract][Full Text] [Related]
17. Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring.
Holt DW; Mandelbrot DA; Tortorici MA; Korth-Bradley JM; Sierka D; Levy DI; See Tai S; Horowitz GL
Clin Transplant; 2014 Feb; 28(2):243-51. PubMed ID: 24476346
[TBL] [Abstract][Full Text] [Related]
18. Comparison of SemiQuantitative Cotinine Values Obtained by the DRI Immunoassay and Values Obtained by a Liquid Chromatography-Tandem Mass Spectrometry-Based Method: The DRI Immunoassay is Suitable for Screening Purposes Only Because Semiquantitative Values May Be Unreliable.
Dixon RB; Dasgupta A
J Clin Lab Anal; 2016 Nov; 30(6):1106-1109. PubMed ID: 27212710
[TBL] [Abstract][Full Text] [Related]
19. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
Darragh A; Snyder ML; Ptolemy AS; Melanson S
Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.
Zhao M; Li G; Qiu F; Sun Y; Xu Y; Zhao L
Ther Drug Monit; 2016 Apr; 38(2):246-52. PubMed ID: 26488205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
